Concomitant invasive pulmonary aspergillosis and Candida zeylanoides bloodstream infection in an acute myeloblastic leukemia patient

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Sep 30, 2015
DOI: https://doi.org/10.22551/2015.07.0203.10046
Ion Antohe Angela Dascalescu Georgiana Butura Amalia Merticariu Catalin Danaila Karina Bilavski Mihaela Zlei Petru Cianga

Abstract

Current management of acute myeloblastic leukemia (AML) involves induction chemotherapy followed by risk stratified consolidation approaches, consisting of high dose chemotherapy or allogeneic stem cell transplantation. AML patients are at high risk of invasive fungal disease, particularly mold infections, due to the leukemia and chemotherapy related immune deficit. We present an AML patient with prolonged fever and neutropenia after induction therapy, during which she developed concomitant Candida zeylanoides bloodstream infection and invasive pulmonary aspergillosis. The response to Caspofungin and Voriconazole therapy was delayed, and this dictated the surgical management of the remnant pulmonary lesions. A histological confirmation of aspergillosis was thus obtained. Evaluation of host risk factors for invasive fungal disease, prompt scale-up of the diagnosis scheme and initiation of antifungal therapy are mandatory in order to ensure patient survival.

##plugins.themes.bootstrap3.article.details##

Keywords

Pulmonary Aspergillosis, Acute Myeloid Leukemia

References
1. van Burik JH, Leisenring W, Myerson D, et al. The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis. An Autopsy Study of 355 Patients. Medicine 1998; 77(4):246-254.
2. Lin SJ, Schranz J, Teutsch SM. Aspergillosis Case-Fatality Rate: Systematic Review of the Literature. Clin Infect Dis 2001; 32:358-366.
3. Rüping MJ, Vehreschild JJ, Cornely OA. Antifungal Treatment Strategies in High Risk Patients. Mycoses 2008; 51(Suppl 2):46-51.
4. Chelgoum Y, Vey N, Raffoux E, et al. Acute Leukemia during pregnancy. A report on 37 patients and review of the literature. Cancer 2005; 104:110-117.
5. Liu P, Li B, Yin R, et al. Development and evaluation of ITS- and aflP-based LAMP assays for rapid detection of Aspergillus flavus in food samples. Can J Microbiol. 2014; 60(9):579-84.
6. Babouee Flury B, Weisser M, Prince Savic S, et al. Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors? BMC Infectious Diseases, 2014; 14:692.
7. Liss B, Vehreschild JJ, Bangard C, et al. Our 2015 approach to invasive pulmonary aspergillosis. Mycoses 2015; 58:375-382.
8. Nucci M, Nouér SA, Cappone D, et al. Early Diagnosis Of Invasive Pulmonary Aspergillosis In Hematologic Patients: An Opportunity To Improve The Outcome. Haematologica 2013; 98:1657-1660.
9. Vehreschild JJ, Ruping MJ, Wisplinghoff H, et al. Clinical Effectiveness of Posaconazole Prophylaxis in Patients with Acute Myelogenous Leukaemia (AML): a 6 year Experience of the Cologne AML Cohort. J Antimicrob Chemother 2010; 65(7):1466-1471.
10. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia. N Engl J Med 2007; 356(4):348–359.
11. Girmenia C, Frustaci AM, Gentile G, et al. Posaconazole Prophylaxis during front-line Chemotherapy of Acute Myeloid Leukemia: a single-center, real-life experience. Haematologica 2012; 97(4):560–567.
12. Sheppard DC, Campoli P, Duarte RF. Understanding Antifungal Prophylaxis with Posaconazole in Hematology Patients: an evolving bedside to bench story. Haematologica 2014; 99(4):603-604.
How to Cite
Antohe, I., Dascalescu, A., Butura, G., Merticariu, A., Danaila, C., Bilavski, K., Zlei, M., & Cianga, P. (2015). Concomitant invasive pulmonary aspergillosis and Candida zeylanoides bloodstream infection in an acute myeloblastic leukemia patient. Archive of Clinical Cases, 2(3), Arch Clin Cases 2015; 2(3):138-144. https://doi.org/10.22551/2015.07.0203.10046
Issue
Vol. 2 No. 3 (2015)
Section
Case Reports

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.

Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.

How to Cite

Antohe, I., Dascalescu, A., Butura, G., Merticariu, A., Danaila, C., Bilavski, K., Zlei, M., & Cianga, P. (2015). Concomitant invasive pulmonary aspergillosis and Candida zeylanoides bloodstream infection in an acute myeloblastic leukemia patient. Archive of Clinical Cases, 2(3), Arch Clin Cases 2015; 2(3):138-144. https://doi.org/10.22551/2015.07.0203.10046